Akleh Subhi I, Bandali Alykhan, Edwards Richard
The Freeman Hospital Newcastle upon Tyne UK.
Clin Case Rep. 2018 Oct 17;6(11):2262-2265. doi: 10.1002/ccr3.1845. eCollection 2018 Nov.
Increasing longevity of heart transplantation recipients and aging donor population accompanied by the older age at transplantation led to an increase in the prevalence of degenerative valvular disease in particular aortic stenosis. TAVI is considered a safe and feasible alternative compared to conventional SAVR in this high-risk population.
心脏移植受者寿命的延长以及供体人群的老龄化,再加上移植时年龄较大,导致退行性瓣膜病尤其是主动脉瓣狭窄的患病率增加。在这一高危人群中,与传统的外科主动脉瓣置换术(SAVR)相比,经导管主动脉瓣置入术(TAVI)被认为是一种安全可行的替代方案。